Preliminary mechanistic studies suggest that GPR115 may enhance tumor cell adhesion and migration by regulating the integrin-FAK signaling axis, or promote tumor angiogenesis by mediating vascular endothelial growth factor (VEGF) secretion (37, 38). Here, PTK2 is linked to neoplasm.